Topical recombinant thrombin at a concentration of 1000 IU/mL reliably shortens in vivo TTH and delivers durable hemostasis in the presence of heparin anticoagulation and clopidogrel platelet inhibition in a rabbit model of vascular bleeding
-
* Corresponding author: W Allan Alexander alxd@zgi.com
Annals of Surgical Innovation and Research 2009, 3:14 doi:10.1186/1750-1164-3-14
No comments have yet been made on this article.